Published in Nat Genet on June 01, 2010
tbvar: A comprehensive genome variation resource for Mycobacterium tuberculosis. Database (Oxford) (2014) 0.79
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med (2003) 24.99
Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2006) 8.90
The immune epitope database 2.0. Nucleic Acids Res (2009) 6.07
Tuberculosis. Lancet (2007) 5.45
Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet (2010) 4.94
How can immunology contribute to the control of tuberculosis? Nat Rev Immunol (2001) 4.36
Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells. PLoS Med (2008) 3.48
Detecting selection using a single genome sequence of M. tuberculosis and P. falciparum. Nature (2004) 3.46
'Nothing is permanent but change'- antigenic variation in persistent bacterial pathogens. Cell Microbiol (2009) 1.37
Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population level. J Virol (2008) 1.28
Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol (2003) 16.82
Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci U S A (2003) 9.15
A genome-scale analysis for identification of genes required for growth or survival of Haemophilus influenzae. Proc Natl Acad Sci U S A (2002) 5.70
Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci U S A (2008) 4.92
Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. Proc Natl Acad Sci U S A (2005) 4.43
High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. PLoS Pathog (2011) 4.10
Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection. Science (2005) 3.49
Genome-wide RNAi screen for host factors required for intracellular bacterial infection. Science (2005) 3.28
Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis. Nat Rev Microbiol (2008) 2.97
Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β. Nat Immunol (2012) 2.34
NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog (2009) 2.31
Characterization of mycobacterial virulence genes through genetic interaction mapping. Proc Natl Acad Sci U S A (2006) 2.29
Construction of a mariner-based transposon for epitope-tagging and genomic targeting. Gene (2002) 2.15
Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisition. Proc Natl Acad Sci U S A (2009) 2.10
Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms. J Immunol (2004) 2.08
Clinical practice. Latent tuberculosis infection in the United States. N Engl J Med (2011) 2.06
Metabolic regulation of mycobacterial growth and antibiotic sensitivity. PLoS Biol (2011) 2.04
Bacterial growth and cell division: a mycobacterial perspective. Microbiol Mol Biol Rev (2008) 2.01
Tryptophan biosynthesis protects mycobacteria from CD4 T-cell-mediated killing. Cell (2013) 1.96
Systematic genetic nomenclature for type VII secretion systems. PLoS Pathog (2009) 1.96
Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosis. Nat Genet (2013) 1.93
Twin RNA polymerase-associated proteins control virulence gene expression in Francisella tularensis. PLoS Pathog (2007) 1.92
Global assessment of genomic regions required for growth in Mycobacterium tuberculosis. PLoS Pathog (2012) 1.85
igr Genes and Mycobacterium tuberculosis cholesterol metabolism. J Bacteriol (2009) 1.82
Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations. Chem Biol (2012) 1.79
Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide. J Exp Med (2009) 1.68
Letting sleeping dos lie: does dormancy play a role in tuberculosis? Annu Rev Microbiol (2010) 1.66
Mycobacterium tuberculosis ClpP1 and ClpP2 function together in protein degradation and are required for viability in vitro and during infection. PLoS Pathog (2012) 1.60
A partner for the resuscitation-promoting factors of Mycobacterium tuberculosis. Mol Microbiol (2007) 1.59
Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother (2005) 1.55
Depletion of antibiotic targets has widely varying effects on growth. Proc Natl Acad Sci U S A (2011) 1.54
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212. Antimicrob Agents Chemother (2011) 1.51
A mycobacterial enzyme essential for cell division synergizes with resuscitation-promoting factor. PLoS Pathog (2008) 1.47
The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria. Mol Microbiol (2004) 1.43
A phosphorylated pseudokinase complex controls cell wall synthesis in mycobacteria. Sci Signal (2012) 1.41
High-resolution definition of the Vibrio cholerae essential gene set with hidden Markov model-based analyses of transposon-insertion sequencing data. Nucleic Acids Res (2013) 1.35
Ebola and quarantine. N Engl J Med (2014) 1.32
Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis. PLoS One (2013) 1.31
The active ClpP protease from M. tuberculosis is a complex composed of a heptameric ClpP1 and a ClpP2 ring. EMBO J (2012) 1.31
A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Infect Immun (2007) 1.27
Phthiocerol dimycocerosate transport is required for resisting interferon-gamma-independent immunity. J Infect Dis (2009) 1.26
Interaction and modulation of two antagonistic cell wall enzymes of mycobacteria. PLoS Pathog (2010) 1.21
Function of a mycobacterial major facilitator superfamily pump requires a membrane-associated lipoprotein. J Bacteriol (2007) 1.19
Nitrile-inducible gene expression in mycobacteria. Tuberculosis (Edinb) (2008) 1.18
ESCRT factors restrict mycobacterial growth. Proc Natl Acad Sci U S A (2008) 1.15
Lipidomic discovery of deoxysiderophores reveals a revised mycobactin biosynthesis pathway in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2012) 1.13
para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis. J Biol Chem (2013) 1.11
Diarylcoumarins inhibit mycolic acid biosynthesis and kill Mycobacterium tuberculosis by targeting FadD32. Proc Natl Acad Sci U S A (2013) 1.11
Role of cholesterol in Mycobacterium tuberculosis infection. Indian J Exp Biol (2009) 1.11
Ebola--an ongoing crisis. N Engl J Med (2014) 1.11
Structural characterization of the Mycobacterium tuberculosis biotin biosynthesis enzymes 7,8-diaminopelargonic acid synthase and dethiobiotin synthetase . Biochemistry (2010) 1.09
Bacterial proteolytic complexes as therapeutic targets. Nat Rev Drug Discov (2012) 1.08
Inhibition of bacterial disulfide bond formation by the anticoagulant warfarin. Proc Natl Acad Sci U S A (2009) 1.08
Transposon site hybridization in Mycobacterium tuberculosis. Methods Mol Biol (2008) 1.06
Mycobacterium tuberculosis Rv2224c modulates innate immune responses. Proc Natl Acad Sci U S A (2008) 1.05
Mycobacterial mistranslation is necessary and sufficient for rifampicin phenotypic resistance. Proc Natl Acad Sci U S A (2014) 1.05
Protein inactivation in mycobacteria by controlled proteolysis and its application to deplete the beta subunit of RNA polymerase. Nucleic Acids Res (2010) 1.03
DNA methylation impacts gene expression and ensures hypoxic survival of Mycobacterium tuberculosis. PLoS Pathog (2013) 1.03
The normalcy of dormancy: common themes in microbial quiescence. Cell Host Microbe (2013) 1.03
Cyclic AMP regulation of protein lysine acetylation in Mycobacterium tuberculosis. Nat Struct Mol Biol (2012) 1.02
Bayesian analysis of gene essentiality based on sequencing of transposon insertion libraries. Bioinformatics (2013) 1.01
Molecular profiling of Mycobacterium tuberculosis identifies tuberculosinyl nucleoside products of the virulence-associated enzyme Rv3378c. Proc Natl Acad Sci U S A (2014) 0.99
Feast or famine: the host-pathogen battle over amino acids. Cell Microbiol (2013) 0.99
Role in metal homeostasis of CtpD, a Co²⁺ transporting P(1B4)-ATPase of Mycobacterium smegmatis. Mol Microbiol (2012) 0.95
HIV-1 replication is differentially regulated by distinct clinical strains of Mycobacterium tuberculosis. PLoS One (2009) 0.94
Mycobacterial Esx-3 requires multiple components for iron acquisition. MBio (2014) 0.93
Biochemical and spatial coincidence in the provisional Ser/Thr protein kinase interaction network of Mycobacterium tuberculosis. J Biol Chem (2014) 0.92
Out of Africa--caring for patients with Ebola. N Engl J Med (2014) 0.92
A novel P(1B)-type Mn2+-transporting ATPase is required for secreted protein metallation in mycobacteria. J Biol Chem (2013) 0.92
Genomic analyses of microbial virulence. Curr Opin Microbiol (2002) 0.91
Differential roles for the Co(2+) /Ni(2+) transporting ATPases, CtpD and CtpJ, in Mycobacterium tuberculosis virulence. Mol Microbiol (2013) 0.91
The abyssomicin C family as in vitro inhibitors of Mycobacterium tuberculosis. Tuberculosis (Edinb) (2010) 0.89
Protein complexes and proteolytic activation of the cell wall hydrolase RipA regulate septal resolution in mycobacteria. PLoS Pathog (2013) 0.89
Endoglycan, a member of the CD34 family, functions as an L-selectin ligand through modification with tyrosine sulfation and sialyl Lewis x. J Biol Chem (2003) 0.89
Leveraging Advances in Tuberculosis Diagnosis and Treatment to Address Nontuberculous Mycobacterial Disease. Emerg Infect Dis (2016) 0.89
Once upon a time. . . improved intermittent therapy for tuberculosis--fact or fable? Am J Respir Crit Care Med (2005) 0.88
Chemical biology and bacteria: not simply a matter of life or death. Curr Opin Chem Biol (2006) 0.87
A new site-specific integration system for mycobacteria. Tuberculosis (Edinb) (2005) 0.86
Ebola in West Africa at one year--from ignorance to fear to roadblocks. N Engl J Med (2014) 0.86
Scaling down: a PCR-based method to efficiently screen for desired knockouts in a high density Mycobacterium tuberculosis picked mutant library. Tuberculosis (Edinb) (2006) 0.84
High-throughput sequencing enhanced phage display identifies peptides that bind mycobacteria. PLoS One (2013) 0.84
New insights into TB physiology suggest untapped therapeutic opportunities. Immunol Rev (2015) 0.83
Identifying essential genes in Mycobacterium tuberculosis by global phenotypic profiling. Methods Mol Biol (2015) 0.83
The complex relationship between mycobacteria and macrophages: it's not all bliss. Cell Host Microbe (2007) 0.83
Mycobacterial recombineering. Methods Mol Biol (2015) 0.83
Metabolic and bactericidal effects of targeted suppression of NadD and NadE enzymes in mycobacteria. MBio (2014) 0.83
The many roads to essential genes. Tuberculosis (Edinb) (2008) 0.82
New genetic approaches shed light on TB virulence. Trends Microbiol (2005) 0.81